sulfonylurea
sulfonylurea is a pharmaceutical drug with 33 clinical trials. Currently 1 active trials ongoing. Historical success rate of 93.1%.
Success Metrics
Based on 27 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
18
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.0%
27 of 30 finished
10.0%
3 ended early
1
trials recruiting
33
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease
Replication of the SAVOR-TIMI Diabetes Trial in Healthcare Claims
Clinical Trials (33)
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease
Replication of the SAVOR-TIMI Diabetes Trial in Healthcare Claims
Replication of the CARMELINA Diabetes Trial in Healthcare Claims
Replication of the TECOS Diabetes Trial in Healthcare Claims
Clinical Outcomes and Healthcare Cost and Resource Utilization (HCRU) in Patients With Type 2 Diabetes and Cardiovascular Disease on 2nd Line Empagliflozin Versus 2nd Line Sulfonylureas
Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin
Study of Sulphonylurea Synergy With DPP4 Inhibitors
Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)
Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)
Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 33